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Summary
Legionella pneumophila, the causative agent of
Legionnaires’ disease, infects and replicates in
macrophages and amoebas. Following internaliza-
tion, L. pneumophila resides in a vacuole structure
called Legionella-containing vacuole (LCV). The
LCV escapes from the endocytic maturation
process and avoids fusion with the lysosome, a
hallmark of Legionella pathogenesis. Interference
with the secretory vesicle transport and avoiding
lysosomal targeting render the LCV permissive for
L. pneumophila intracellular replication. Central to
L. pneumophila pathogenesis is a defect in the
organelle trafficking/intracellular multiplication
(Dot/Icm) type IV secretion system that translo-
cates a large number of effector proteins into host
cells. Many of the Dot/Icm effectors employ diverse
and sophisticated biochemical strategies to
manipulate the host vesicular transport system,
playing an important role in LCV biogenesis and
trafficking. Similar to other bacterial pathogens,
L. pneumophila also delivers effector proteins to
modulate or counteract host innate immune
defence pathways such as the NF-kB and apop-
totic signalling. This review summarizes the known
functions and mechanisms of Dot/Icm effectors
that target host membrane trafficking and innate
immune defence pathways.
Gram-negative Legionella pneumophila is an environ-
mental pathogen that normally replicates within a proto-
zoan host. L. pneumophila is an opportunistic human
pathogen, and the infection causes an acute form of
pneumonia known as Legionnaires’ disease (Fraser et al.,
1977). The disease is associated with efficient replication
of L. pneumophila within monocytes and alveolar mac-
rophages with the latter being the primary site of bacterial
growth (Horwitz and Silverstein, 1980; Nash et al., 1984).
Internalized L. pneumophila forms a distinct Legionella-
containing vacuole (LCV) (Fig. 1) (Horwitz, 1983a,b) that
is negative for canonical markers of the endocytic
pathway such as Rab5 for early endosomes, Rab7 for late
endosomes and LAMP-1 for lysosomes (Roy et al., 1998;
Clemens et al., 2000). The LCV does not undergo acidi-
ﬁcation and maintains a pH of ~ 6.1 (Horwitz and Maxﬁeld,
1984). Indeed, LCV escape from lysosomal fusion is a
hallmark of Legionella pathogenesis and mutant bacteria
deﬁcient in this capability are essentially avirulent
(Horwitz, 1987). L. pneumophila eventually ruptures the
LCV membrane and lyses the macrophages (Fig. 1),
resulting in bacterial release into the extracellular milieu
and initiation of infection of adjacent host cells.
The LCV becomes surrounded by smooth vacuoles,
mitochondria and ribosomes at 15 min, 4 h and 8 h after
infection respectively (Fig. 1) (Horwitz, 1983b). The mem-
brane thickness of LCV changes to resemble that of endo-
plastic reticulum (ER) within 15 min post infection,
suggesting that the smooth vacuoles are ER-derived
(Tilney et al., 2001). Small GTPases, like Rab1, Sar1 and
ADP ribosylation factor 1 (Arf1), which are critical for
ER-to-Golgi trafficking, are recruited to the LCV (Kagan
and Roy, 2002; Derre and Isberg, 2004; Kagan et al.,
2004). The ER-derived vesicles are subsequently fused to
the LCV as indicated by the presence of ER-resident
proteins in the lumen of the LCV (Swanson and Isberg,
1995; Abu Kwaik, 1996; Robinson and Roy, 2006). Four
hours post infection, ER-derived smooth vesicles, as well
as mitochondria, start to disappear from the LCV. Concur-
rently, the LCV becomes studded with ribosomes, turning
the LCV into a rough ER-like vacuole (Fig. 1). Dominant-
negative inhibition of Sar1 or Arf1 function decreases
L. pneumophila replication in mammalian cells (Kagan
and Roy, 2002). Knockdown of a single component of
ER-associated degradation machinery (Cdc48/p97 and
its cofactors) or a combinatory knockdown of Sec22 and
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cellular microbiologymembers of the transport protein particle (TRAPP)
complex also can inhibit L. pneumophila replication in
Drosophila Kc167 cells (Dorer et al., 2006). These ﬁnd-
ings suggest a potentially important role for hijacking host
secretory organelles and recruitment of ER-derived vacu-
oles in establishing the replication-permissive LCV. Differ-
entiation of the LCV into an ER-like compartment is
believed to be vital for avoiding lysosomal fusion despite
the lack of direct evidence due to high genetic redundancy
(discussed below).
L. pneumophila Dot/Icm type IV secretion system
Two independent genetic studies identiﬁed the defect in
organelle trafficking/intracellular multiplication (Dot/Icm)
loci as being required for recruitment of ER-derived
vesicles to the LCV and inhibition of phagosome–
lysosome fusion (Fig. 1) (Marra et al., 1992; Berger and
Isberg, 1993). The Dot/Icm loci encode 27 proteins that
assemble into a sophisticated translocation apparatus,
the type IVB secretion system (Segal et al., 1998; Vogel
et al., 1998; Komano et al., 2000). The Dot/Icm type IV
secretion system is evolutionarily related to bacterial
conjugative DNA-transfer apparatuses, but is now estab-
lished as a protein translocation channel. The Dot/Icm
system is also critical for other aspects of Legionella
pathogenesis. For example, Dot/Icm-dependent upregu-
lation of proinﬂammatory cytokines and activation of host
NF-kB and the JNK/p38 mitogen-activated protein kinase
signalling have been reported (Shin et al., 2008; Bartfeld
Fig. 1. Life cycle of L. pneumophila in host cells. Wild-type L. pneumophila is taken up by macrophages through coiling phagocytosis and
resides in a LCV. Rapid association of smooth vesicles and mitochondria with LCVs occurs after phagocytosis. The smooth vesicles are
derived from endoplasmic reticulum (ER) and decorate LCVs into ER-like vacuoles that are permissive for L. pneumophila replication. Later
on, LCVs are studded with ribosomes, and within these compartments, L. pneumophila replicates efficiently and eventually lyses the host cell.
For dot/icm-deﬁcient L. pneumophila, the LCV loses the ability of recruiting smooth vesicles, mitochondria and ribosomes, but instead
undergoes the normal endocytic maturation process. The avirulent mutant bacteria are therefore cleared upon phagosome–lysosome fusion.
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suppression of host cell apoptosis (Abu-Zant et al., 2005;
2007; Losick and Isberg, 2006) and inhibition of the inter-
feron pathway (Monroe et al., 2009).
Several approaches have been undertaken to identify
genes encoding the Dot/Icm-secreted effectors. These
include bioinformatics searches based on the presence
of eukaryotic-speciﬁc domains or post-translational modi-
ﬁcation motifs (Nagai et al., 2002; Cazalet et al., 2004;
de Felipe et al., 2005; Bruggemann et al., 2006; Ivanov
et al., 2010), sequence features identiﬁed from known
effectors (Zusman et al., 2007; 2008; Burstein et al.,
2009), or the presence of a putative C-terminal trans-
location motif called E Block (Huang et al., 2011). Experi-
mental approaches, including direct examination of Dot/
Icm-dependent translocation into host cytosol (Luo and
Isberg, 2004; de Felipe et al., 2008; Zhu et al., 2011),
heterologous expression in yeast (Campodonico et al.,
2005; Shohdy et al., 2005; Heidtman et al., 2009), inter-
action with Dot/Icm apparatus components (IcmW/IcmS)
(Conover et al., 2003; Luo and Isberg, 2004; Bardill et al.,
2005), and proteomic analysis (Hayashi et al., 2010), have
led to identiﬁcation of a number of additional Dot/Icm
effectors. These analyses together have now provided
more than 250 Dot/Icm-secreted proteins (Zhu et al.,
2011). This unexpectedly large number is consistent with
the fact that loss of a single effector rarely causes a severe
defect in intracellular growth or other virulence traits.
Effectors that have been reported to have biochemical or
cellular functions in manipulating the host membrane traf-
ﬁcking system and innate immune defence (Fig. 2) are
discussed in detail below.
Dot/Icm effectors targeting small GTPases in
vesicular trafficking
Ras-like small GTPases in eukaryotes exist in two confor-
mational states: the GTP-bound active state that can
interact with downstream signalling molecules and the
GDP-bound inactive state. GTPase-activating proteins
(GAPs) stimulate the intrinsic GTP hydrolytic activity of
the GTPase while guanine nucleotide exchange factors
(GEFs) catalyse the exchange of GDP for GTP and acti-
vate the GTPase. Guanosine nucleotide dissociation
inhibitors (GDIs) extract the lipid-modiﬁed GTPases from
the membrane and maintain them in the GDP-bound state.
Arf1 and Rab1, two Ras-like GTPases involved in
ER-Golgi trafficking, are associated with the LCV in
Legionella infection (Kagan and Roy, 2002; Derre and
Isberg, 2004; Kagan et al., 2004). RalF, the ﬁrst L. pneu-
mophila Dot/Icm substrate identiﬁed due to its N-terminal
Sec7-homology domain, mediates LCV recruitment ofArf1
(Nagai et al., 2002). The Sec7-homology domain is widely
expressed in eukaryotic Arf-GEFs and RalF also displays
an Arf-GEF activity in vitro (Fig. 2). RalF colocalizes with
Arf1 and activates it on the LCV after bacterial internaliza-
tion. Sec7-like Arf-GEF usually harbours a catalytically
essential glutamic acid. Mutations of the corresponding
Glu103 in RalF ablate the ability of RalF to recruit Arf1 to
the LCV, but intriguingly, they do not affect the in vitro
Arf-GEF activity (Amor et al., 2005).The 374-residue RalF
contains a C-terminal domain that interacts intramolecu-
larly with the Arf-GEF domain (Amor et al., 2005). The
presence of the C-terminal domain increases RalF Arf-
GEF activity by more than 10-fold despite that it buries the
active site Glu103. RalF Arf-GEF activity requires the
addition of lipids; the C-terminal domain is proposed to act
as a lipid-binding domain to anchor RalF onto the LCV
membrane. A complex structure of RalF and Arf1 will be
helpful for improving the understanding of the role of the
C-terminal domain in stimulating RalF Arf-GEF activity.
Dominant-negative and pharmacological inhibition studies
suggest that Arf1 function is essential for LCV biogenesis
as well as efficient fusion with ER-derived vesicles (Kagan
and Roy, 2002; Robinson and Roy, 2006). However, dele-
tion of RalF does not affect Legionella intracellular replica-
tion (Nagai et al., 2002). Given that small GTPase cycles
betweenGDP-andGTP-boundformsforappropriatefunc-
tioning, it is possible that L. pneumophila may harbour
other effectors to inactive Arf1.
Rab1 is recruited onto the LCV by a Dot/Icm effector
called SidM or DrrA. The 73 kD SidM/DrrA effector was
identiﬁed by two complementary approaches. Machner
et al. pulled down SidM from L. pneumophila lysates
using a Rab1 S25N mutant as the bait (Machner and
Isberg, 2006). Murata et al. isolated SidM (named DrrA in
this work) from a visual screen to look for L. pneumophila
transposon mutants defective in LCV recruitment of Rab1
(Murata et al., 2006). SidM/DrrA acts as a potent Rab1-
speciﬁc GEF despite the lack of sequence homology to
eukaryotic Rab-GEFs. SidM/DrrA harbours an additional
GDI displacement factor (GDF) activity that promotes the
release of Rab1 from GDI (Ingmundson et al., 2007;
Machner and Isberg, 2007). The complex structure of
SidM/DrrA and nucleotide-free Rab1 reveals a central
Rab1-activation domain that harbours both GEF and GDF
activities (Schoebel et al., 2009; Suh et al., 2010; Zhu
et al., 2010). SidM/DrrA binding triggers a drastic dis-
placement of switch I of Rab1, resulting in coupled GDP
release and GDI displacement. The unique dual activities
of SidM/DrrA allow the pathogen to efficiently recruit and
activate the cytosolic pool of Rab1. SidM/DrrAis anchored
onto the LCV membrane by a novel phosphatidylinositol
4-phosphate (PI(4)P)-binding domain at its C-terminal
region (Brombacher et al., 2009; Schoebel et al., 2010;
Zhu et al., 2010).
The structure of SidM/DrrA N-terminal domain (SidM-
NTD) reveals an unexpected similarity to the catalytic
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(GS-ATase) (Muller et al., 2010). SidM-NTD efficiently
catalyses AMP transfer to a conserved tyrosine in the
switch II region in Rab1-GTP (Tyr77 in Rab1B). This ade-
nylylation or AMPylation modiﬁcation inhibits GAP-
stimulated GTP hydrolysis, securing Rab1 in the active
state. L. pneumophila harbours two effectors that switch
off SidM/DrrA-mediated activation of Rab1. SidD, a
protein comprising 507 amino acids, removes AMP from
Rab1 (Neunuebel et al., 2011; Tan and Luo, 2011). Fold
recognition analysis predicts the existence of a metal-
dependent protein phosphatase (PPM) fold in SidD
(Rigden, 2011), suggesting a protein phosphatase-like
catalytic mechanism for deadenylylation/deAMPylation.
Ectopically expressed SidD is enriched in the Golgi, and
can counteract SidM-NTD-induced Golgi fragmentation
and cell death (Neunuebel et al., 2011). Deletion of SidD
from L. pneumophila results in a prolonged localization of
Fig. 2. Summary of functionally characterized Dot/Icm effectors targeting host vesicular transport and innate immune defence system. Arf1 is
recruited to the LCV by Dot/Icm effector RalF, a Sec7-like Arf-GEF that activates Arf1 on the LCV. The SidM/DrrA effector recruits and
activates Rab1 onto the LCV using its GEF and GDF activities. The additional N-terminal adenylyl transferase-like domain of SidM/DrrA further
modiﬁes Rab1-GTP by adenylylating Tyr77 in Rab1 to lock Rab1 in the GTP-bound form, thereby prolonging the duration of Rab1 in the active
state. SidD harbours a novel deadenylylation/deAMPylation activity to remove the AMP moiety from Rab1, which allows the Rab-GAP LepB to
inactivate Rab1 and remove it from the LCV. LidA facilitates SidM/DrrA-mediated Rab1 recruitment and likely serves as a Rab effector to
signal downstream membrane fusion events. AnkX functions by preventing minus end-directed vesicular transport on microtubules and its Fic
domain catalyses the transfer of a phosphocholine moiety from CDP-choline to a serine residue in Rab1. Another ankyrin repeat-containing
effector, AnkB contains an F-box motif that functions, together with host Skp1 and Cullin1, to form a SCF ubiquitin ligase complex. This activity
of AnkB is required for decorating the LCV with polyubiquitinated proteins. Four other effectors are involved in modulating host innate immune
defence pathways. LegK1 and LnaB both can potently activate the NF-kB pathway in vitro. The prokaryotic serine/threonine kinase LegK1
mimics host IKK and phosphorylates the IkB family of NF-kB inhibitors, resulting in degradation of IkB and nuclear translocation of NF-kB
transcriptional factors. The host target of LnaB and its mechanism of action are currently unknown. SidF and SdhA suppress host apoptosis
following L. pneumophila infection. SidF targets BNIP3 and Bcl-rambo, two pro-apoptotic members of the Bcl2 family. SdhA is genetically more
important as its deletion signiﬁcantly impaired intracellular replication and increased host cell death. SdhA also functions to inhibit Legionella
infection-induced type I interferon response, stressing its important role in counteracting the host defence system.
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observed with L. pneumophila lepB- mutant (Ingmundson
et al., 2007). The LepB effector harbours a Rab1-speciﬁc
GAP activity, but shows no sequence similarity to any
eukaryotic Rab-GAP. Inactivation of Rab1 and subse-
quent removal of Rab1 from the LCV by LepB requires
SidD-catalysed deadenylylation/deAMPylation. The se-
quential action of SidM/DrrA-mediated nucleotide
exchange and adenylylation/AMPylation, SidD-catalysed
deadenylylation/deAMPylation, and LepB-catalysed GTP
hydrolysis/inactivation of Rab1 represents a unique regu-
latory cycle of Rab1 on the LCV (Fig. 2). This is supported
by sequential production of the three effectors during
L. pneumophila infection; levels of SidD and LepB
increase as SidM/DrrA decreases (Ingmundson et al.,
2007; Neunuebel et al., 2011). Notably, genes encoding
the three are clustered together in the L. pneumophila
genome with SidM/DrrA SidD, and LepB, encoded in that
order. The lepB- mutant strain exhibits replication defects,
but this is unlikely a result of prolonged Rab1 activation as
deletion of either SidD or SidM/DrrA causes no such
defects (Neunuebel et al., 2011). LepB, together with
another effector LepA, which has an unknown function,
was originally identiﬁed as an essential factor for the
exocytosis-based nonlytic release of bacteria from
infected protozoan cells (Chen et al., 2004). Given the
large size of LepB (> 1300 amino acids), these observa-
tions suggest that LepB may harbour other functions in
addition to promoting Rab1 GTP hydrolysis.
Two other Dot/Icm effectors, AnkX and LidA, are also
known to target Rab1. AnkX was originally demonstrated
to prevent minus end-directed vesicle transport on micro-
tubules (Pan et al., 2008). AnkX was recently shown to
harbour an enzymatic activity of transferring a phos-
phocholine moiety from CDP-choline to a serine residue
preceding the SidM/DrrA-modiﬁed tyrosine residue in
Rab1 as well as Rab35 (Fig. 2) (Mukherjee et al., 2011).
The biochemical properties of AnkX-mediated phos-
phocholination of Rab1 are similar to adenylylation/
AMPylation, but the exact biological consequence of this
new modiﬁcation during infection needs further investi-
gation. The 729-residue LidA effector binds GDI-free
Rab1 but has a higher affinity for Rab1-GTP (Conover
et al., 2003). Overproduction of LidA in mammalian cells
causes disruption of the early secretory pathway (Derre
and Isberg, 2005). LidA is localized to the surface of LCV
and promotes SidM/DrrA-mediated recruitment of Rab1-
containing ER vesicles (Machner and Isberg, 2006). LidA
is proposed to be a Rab1 effector (Fig. 2). If this is true,
L. pneumophila may rewire host Rab1 signalling by pro-
viding LidA, which potentially engages host proteins
that are not normally subjected to regulation by Rab1.
Consistent with this hypothesis, SidM/DrrA-catalysed
adenylylation/AMPylation has been shown to block Rab1
binding to host effectors, such as MICAL-3, but not to
LidA (Muller et al., 2010).
Ankyrin repeat effectors in LCV trafficking
and transport
Legionella pneumophila encodes 11 proteins with various
numbers of ankyrin repeats (Habyarimana et al., 2008).
The ankyrin repeat is a 33-residue motif that usually medi-
ates protein–protein interaction in eukaryotes. This group
of Dot/Icm effectors (de Felipe et al., 2005; Pan et al.,
2008; Habyarimana et al., 2010; Zhu et al., 2011), com-
prised of 172 to 949 amino acids, shares no detectable
sequence similarity outside of the ankyrin repeats. Four of
the ankyrin repeat effectors (AnkB,AnkH,AnkJ andAnkX/
AnkN/LegA8) are associated with distinct membrane
structures when expressed in mammalian cells (Pan
et al., 2008; Habyarimana et al., 2010; Price et al., 2010).
AnkX is one of the very few Dot/Icm effectors that, when
deleted, results in acquisition of late endosomal markers
on the LCV although it is dispensable for intracellular
replication (Pan et al., 2008).AnkX causes severe defects
in the sorting of secretory proteins to the vacuole in yeast
(Heidtman et al., 2009) and disruption of the Golgi in
mammalian cells (Pan et al., 2008). AnkX functions by
preventing minus end-directed vesicle transport on micro-
tubules; this function is dependent on the four-ankyrin
repeats. AnkX contains an additional Fic domain that is
also required for inducing Golgi fragmentation (Pan et al.,
2008; Roy and Mukherjee, 2009). The Fic domain was
recently demonstrated to have enzymatic activity; it pro-
motes the catalysis of the adenylylation/AMPylation modi-
ﬁcation (Worby et al., 2009; Yarbrough et al., 2009),
similarly to SidM-NTD. The Fic domain in AnkX is indeed
responsible for the phosphocholination modiﬁcation of
Rab1 and Rab35 described above (Mukherjee et al.,
2011). Further studies are needed to understand the func-
tional consequence of AnkX-induced phosphocholination
of Rab proteins, particularly in view of its unique and
important role in interfering with microtubule-directed
vesicular transport.
AnkB contains an F-box motif and two ankyrin repeats.
F-box proteins usually serve as substrate-recruiting adap-
tors for a class of RING-domain ubiquitin ligase com-
plexes called Skp1/Cullin1/F-box (SCF) (Petroski and
Deshaies, 2005). Assembly of functional SCF complexes
is critical for L. pneumophila replication (Price et al.,
2009). Ectopically expressed AnkB colocalizes with Skp1
at the cell periphery and recruits polyubiquitinated pro-
teins (Price et al., 2009; Lomma et al., 2010). The two
ankyrin repeats in AnkB are responsible for its membrane
targeting (Price et al., 2010). AnkB is essential for LCV
acquisition of polyubiquitinated proteins in both macroph-
age and amoeba hosts (Fig. 2), which is dependent on the
1874 J. Ge and F. Shao
© 2011 Blackwell Publishing Ltd, Cellular Microbiology, 13, 1870–1880F-box motif (Price et al., 2009). Controversial results
regarding the genetic requirement of AnkB for successful
L. pneumophila infection have been reported (Al-Khodor
et al., 2008; Price et al., 2009; Ensminger and Isberg,
2010; Lomma et al., 2010), and this might result from the
use of different bacterial strains. The ankh- and ankJ-
mutants display a partial growth defect in macrophage
and protozoan hosts without affecting trafficking of the
LCV (Habyarimana et al., 2008). The ankyrin repeats in
AnkH and AnkJ are also important for their function, but
their exact role is less deﬁned (Habyarimana et al., 2010).
Other effectors potentially functioning in modulating
host membrane trafficking
Yeast is a powerful model system for functional charac-
terization of bacterial effectors. Nine Dot/Icm effectors,
including VipA, VipD, VipF, LegC3, YlfA/LegC7, YlfB/
LegC2 (a paralogue of YlfA), SetA, Ceg19 and Ceg9,
have been found to cause protein sorting or secretion
defects in yeast (de Felipe et al., 2005; Shohdy et al.,
2005; Heidtman et al., 2009). Most of these effectors
target distinct steps in yeast vesicular trafficking while
exhibiting a speciﬁc membrane/secretory organelle-
associated localization in mammalian cells. For example,
YlfB/LegC2 and YlfA/LegC7 colocalize with ER markers
but exclude lysosomal markers; SetA is localized to late
endosomal/lysosomal compartments. These nine effec-
tors likely function in LCV remodelling and trafficking,
but their host targets and biochemical functions are not
known. However, SetA has been shown to have a
functionally important glycosyltransferase domain and is
ubiquitinated in host cells and VipF contains an acetyl-
transferase domain. In a search for effectors that affect
yeast growth at neutral, but not acidic pH, Xu et al. iden-
tiﬁed the SidK effector (Xu et al., 2010). SidK blocks vacu-
olar H+-mediated ATP hydrolysis and proton translocation
by directly interacting with the ATP hydrolysing subunit of
vacuolar H+-ATPases, VatA. Macrophages loaded with
recombinant SidK exhibit defects in phagosomal acidiﬁ-
cation and bacterial killing, implicating a role of SidK in
preventing LCV acidiﬁcation.
Homology to eukaryotic proteins is a strong indicator of
a secreted effector and may provide further functional
insights. Many Dot/Icm effector genes are named as Leg,
standing for Legionella eukaryotic-like gene (de Felipe
et al., 2005; 2008). LegK2, a eukaryotic-like serine/
threonine kinase, functions in ER recruitment to the LCV
and contributes to L. pneumophila growth in amoeba
(Hervet et al., 2011). LegS2 is homologous to eukaryotic
sphingosine-1-phosphate lyase and localizes to the mito-
chondria in host cells (Degtyar et al., 2009). LegS2, but
not its catalytically inactive mutant, rescues the yeast
sphingosine-sensitive phenotype and delays secretory
protein trafficking to the yeast vacuole (Heidtman et al.,
2009). Generally, it is believed that bacterial effector
genes are acquired through horizontal transfer and this
often results in high genomic plasticity in the effector-
coding region. This feature leads to identiﬁcation of a
group of Dot/Icm effectors known as Plasticity Island of
Effectors (Pies, PieA to PieG, PpeA, PpeB and PpgA)
(Ninio et al., 2009). Most of the Pie effectors contain
coiled-coil regions; PieG and PpgA contain a RCC1
domain that is linked to eukaryotic GEFs for Ran-GTPase
activity. None of the Pie effectors are essential for intrac-
ellular replication, but several of them have distinct intra-
cellular membrane localization in mammalian cells. PieA
is recruited to the cytoplasmic face of the LCV and over-
expression alters lysosome morphology through an
unknown mechanism. It is likely that some Pie effectors
are involved in LCV remodelling and trafficking.
SidC, SdcA(a SidC paralogue) and SidJ are three other
effectors shown to be important for LCV recruitment of
ER-derived vesicles (Liu and Luo, 2007; Ragaz et al.,
2008). SidC and SdcA are further required for LCV tran-
sition from a ‘tight’ to a ‘spacious’ vacuole in Dictyostelium
discoideum. A 70 kDa recombinant fragment of the 917-
residue protein, SidC, is capable of recruiting ER vesicles
in vitro. The C-terminal region of SidC contains a unique
PI(4)P-binding domain and could be potentially used as a
PI(4)P-speciﬁc probe (Ragaz et al., 2008). SidC and
SdcA play minor roles in maintaining LCV membrane
integrity; L. pneumophila deﬁcient in both effectors repli-
cates as efficiently as the wild-type strain. In contrast to
SidC and SdcA, deletion of SidJ causes a severe growth
defect in both the macrophage and amoeba host while its
paralogue, SdjA, plays a minor role only in the amoeba
(Liu and Luo, 2007). The functional mechanisms of these
effectors have not yet been deﬁned.
Legionella pneumophila also produces effectors that
directly act on membrane phospholipids. At least 15
genes encoding putative phospholipases are present in
the L. pneumophila genome. These genes can be placed
into three major groups according to their sequence
homology and domain features: the GDSL, the patatin-
like, and the PlaB-like enzymes (Lang and Flieger, 2011).
Among the 15 phospholipases, VipD and its two paral-
ogues, VpdA and VpdB, all of which belong to the patatin-
like family, are experimentally conﬁrmed Dot/Icm effectors
(Shohdy et al., 2005; VanRheenen et al., 2006; Lang and
Flieger, 2011). VipD was ﬁrst identiﬁed in a screen for
L. pneumophila effectors that block membrane trafficking
in yeast (Shohdy et al., 2005). VipD interferes with multi-
vesicular formation in the late endosome and thereby
inhibits lysosomal trafficking. VipD is homologous to the
type III effector, ExoU, expressed by Pseudomonas
aeruginosa. In contrast to ExoU, VipD, as well as the 14
other putative phospholipase, has not been demonstrated
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potential role in modulating the host membrane system.
Modulation of host innate immune signalling by
Dot/Icm effectors
NF-kB signalling controls gene expression for multiple
cellular processes including inﬂammation, innate immu-
nity and apoptosis. Transcriptional proﬁling demonstrates
that L. pneumophila infection of macrophages upregu-
lates a number of cytokines, many of which are targets of
the NF-kB pathway (Losick and Isberg, 2006; Shin et al.,
2008; Fontana et al., 2011). While activation of some
proinﬂammatory cytokines is mainly mediated by engage-
ment of host pattern recognition receptors, Dot/Icm-
secreted effectors are also important in stimulating host
innate immune responses (Losick and Isberg, 2006; Shin
et al., 2008; Fontana et al., 2011). This is particularly inter-
esting given that bacterial pathogens usually use secreted
effectors to block the host innate immune response.
Dot/Icm-dependent activation of NF-kB signalling is a
sustained response in both macrophages and alveolar
epithelial cells, as demonstrated by nuclear localization
followedbynuclearretentionofNF-kBp65for30 h(Losick
and Isberg, 2006; Abu-Zant et al., 2007; Bartfeld et al.,
2009). This response is required for host cell survival after
infection, and activation of certain NF-kB-controlled anti-
apoptotic genes renders infected macrophages resistant
to apoptotic stimuli. Two effectors, LegK1 and LnaB, were
identiﬁed by screening a library of more than 100 effectors
for NF-kB luciferase reporter activation in 293T cells (Ge
et al., 2009; Losick et al., 2010). The activity of LegK1 is
speciﬁc as it does not affect mitogen-activated protein
kinase or interferon pathways (Ge et al., 2009). The
canonical serine/threonine kinase activity of LegK1 is
essential for potent activation of the NF-kB pathway, which
can be reconstituted in cell-free extracts. LegK1 mimics
host IKK and directly phosphorylates the Ser32 and Ser36
residues of the inhibitory IkBa protein (Fig. 2), leading to
IkBa ubiquitination/degradation and subsequent nuclear
translocation of p65 (Ge et al., 2009). LegK1 is distinct
from host IKK; it is constitutively active and does not
require phosphorylation-induced activation. LegK1 is the
ﬁrst bacterial effector that activates host NF-kB signalling
via a known biochemical mechanism (Ge et al., 2009). In
contrast to LegK1, the 558-residue protein, LnaB, displays
no sequence homology to any known proteins. Activation
of NF-kB signalling requires a central coiled-coil region
and the C-terminal region localizes ectopically expressed
LnaB to the perinuclear region, reminiscent of the ER
compartment. A partial reduction in the expression of an
NF-kB luciferase reporter has been observed in 293Tcells
infected with a lnaB- mutant (Losick et al., 2010).
However, neither LnaB nor LegK1 is responsible for
infection-induced sustained NF-kB activation, and the two
effectors contribute little to intracellular replication of
L. pneumophila. Interestingly, LegK1 can also phosphory-
late the IkBa-like p100 protein, resulting in its maturation
into the p52 form and activation of the non-canonical
NF-kB signalling in vitro (Ge et al., 2009). The functional
signiﬁcance of this biochemical observation is currently
unknown.
NF-kB signalling is subjected to negative feedback
regulation by resynthesis of NF-kB signalling inhibitors
such as IkBa and A20. In fact, IkBa fails to recover to
baseline level even at 2 h post infection with wild-type
L. pneumophila, but not the Dot/Icm mutant, suggesting
that Dot/Icm-mediated inhibition of IkBa/A20 synthesis
might be responsible for infection-induced, prolonged
NF-kB activation (Fontana et al., 2011). Five L. pneumo-
phila effectors, including Lgt1, Lgt2, Lgt3, SidI and SidL,
are known to target host translational machinery and
thereby block protein synthesis (Belyi et al., 2006; 2008;
Shen et al., 2009). Deletion of the ﬁve effectors from
L. pneumophila leads to a decreased nuclear localization
of p65 and a partial recovery of IkBa during infection.
Thus, effector-mediated inhibition of translation, at least
partially, contributes to L. pneumophila-induced sustained
NF-kB activation. However, it is not known how these
effectors selectively inhibit synthesis of a portion of NF-kB
targets.
Recent studies have demonstrated that nuclear acid-
activated interferon responses play a crucial role in coun-
teracting bacterial infection. Both IFN-g and IFN-a/b can
restrict L. pneumophila intracellular growth (Opitz et al.,
2006; Plumlee et al., 2009). L. pneumophila infection acti-
vates the type I interferon response in a Dot/Icm-
dependent manner (Stetson and Medzhitov, 2006). Both
L. pneumophila DNA and RNA are proposed to be
responsible for this effect (Stetson and Medzhitov, 2006;
Chiu et al., 2009; Plumlee et al., 2009). A transposon
screen identiﬁed the Dot/Icm effector SdhA, previously
known to be required for blocking macrophage apoptosis
(see below) (Laguna et al., 2006), as an inhibitor of the
type I interferon response (Monroe et al., 2009). Ectopic
expression of SdhAalone inhibits artiﬁcial activation of the
interferon pathway. It is certainly possible that additional
effectors involved in modulating host innate immune sig-
nalling might exist given the large number of functionally
uncharacterized Legionella effectors.
Counteracting the host apoptotic program by
Dot/Icm effectors
Legionella pneumophila-infected macrophages, though
showing caspase-3 activation, are resistant to exogenous
apoptotic stimuli (Abu-Zant et al., 2005). This has been
attributed to Dot/Icm-dependent sustained activation of
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effectors, SidF and SdhA, may also play important roles in
this process (Fig. 2) (Laguna et al., 2006; Banga et al.,
2007). Macrophages infected with either sidF- or sdhA-
mutant bacteria display increased apoptosis and, in the
latter case, a more severe phenotype is observed. SdhA
was identiﬁed through a genetic screen of L. pneumophila
mutants that had intracellular growth defects. Infection
with the sdhA- mutant is associated with increased
caspase activation and mitochondrial disruption (Laguna
et al., 2006), suggesting that SdhA likely suppresses a
mitochondria-mediated pro-apoptotic pathway. In contrast
to SdhA, SidF alone is sufficient to inhibit apoptosis; SidF-
expressing mammalian cells become more resistant to
apoptotic stimuli. A C-terminal portion of SidF interacts
with BNIP3 and Bcl-rambo, two pro-apoptotic members of
the Bcl2 family (Fig. 2) (Banga et al., 2007). SidF inhibits
Bcl-rambo-induced apoptosis in an ectopic expression
assay, but whether this occurs during macrophage infec-
tion is not currently known. Deletion of SidF leads to a
threefold decrease in L. pneumophila replication in mouse
primary macrophages, but not in human U937 monocytes
and amoeba. In contrast, a much more severe growth
defect is observed when cells are infected with the sdhA-
mutant, particularly with primary mouse macrophages.
SdhA is a large protein of 1429 residues with no recog-
nizable domains and it possibly targets multiple proteins
to affect various host processes. SdhA has two paral-
ogues SidH and SdhB that play only minor roles, if any, in
L. pneumophila replication (Laguna et al., 2006). Thus,
Dot/Icm-mediated inhibition of macrophage apoptosis
likely has a critical role in establishing an intracellular
environment permissive for Legionella replication.
Concluding remarks and future perspectives
Pathogenesis of L. pneumophila relies on the Dot/Icm
type IV secretion system that injects at least 250 effectors
into host cells. This unusually large effector repertoire
likely reﬂects an extensive engagement with host cellular
processes along the evolution of bacterial virulence. Such
a large number of effector proteins also pose a challenge
to Legionella research; studies examining Legionella
effector function and virulence mechanisms were often
complicated due to genetically redundant roles of the
multiple effectors. However, over the past few years,
intensive biochemical studies have improved our under-
standing of certain aspects of Legionella pathogenesis. In
particular, identiﬁcation of Rab1 as a host target and elu-
cidation of the biochemical activities of SidM/DrrA
(adenylylation/GEF/GDF), SidD (deadenylylation), LepB
(GAP) and LidA (Rab1 effector) have provided a near
complete picture of how Legionella modulates Rab1 func-
tion during LCV interaction with ER-derived vesicles.
These exciting discoveries also highlight the diverse and
sophisticated biochemical strategies employed by
L. pneumophila to interplay with key host processes, par-
ticularly given the large repertoire of Dot/Icm effectors that
have undeﬁned biochemical activities. More importantly,
the unique mechanisms of regulating Rab1 activity by
SidM/DrrA, LepB and SidD are also insightful and provide
a new understanding of the regulation of Rab1 and,
potentially, other host small GTPase functions. These
fruitful studies have several additional implications for
future studies of Legionella effectors and their roles in
modulating other aspects of LCV trafficking as well as
host innate immunity. First, measurement of the contribu-
tion to intracellular replication has been historically used
to analyse the genetic function of a particular effector. This
emphasis, though intuitively important, has proven to be
less useful due to multiple and redundant mechanisms
employed by L. pneumophila. Therefore, a more deﬁned
cell biological phenotype, such as Rab1 recruitment to
and removal from LCVs, shall be more helpful. Second, a
combination of genetic, cellular, biochemical and struc-
tural approaches is necessary for analysing effector func-
tion. And, ﬁnally, multiple effectors may function
cooperatively to achieve accurate and controlled regula-
tion of a particular host process. This is often reﬂected in
the temporal and spatial regulation of these effectors
(Neunuebel et al., 2011). With these points in mind, better
understanding of Legionella pathogenesis through func-
tional dissection of more Dot/Icm effectors in future
studies is anticipated.
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